
DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
Chesnara Plc (LON:CSN) is the topic of conversation when Dr Brian Moretta joins DirectorsTalk Interviews. Brian talks us through his recent note on the company entitled ‘Good first half, aided..
4Global Plc (LON:4GBL) CEO Eloy Mazon joins DirectorsTalk Interviews to discuss contracts wins in the Middle East and in Guadalajara, Mexico. Eloy talks us through a positive trading update recently,..
NB Private Equity Partners (LON:NBPE) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. In this interview Mark provides an overview of his..
Pennant International Group (LON:PEN) CEO, Phil Walker joins DirectorsTalk Interviews to discuss interim results for the six months ended 30 June 2023. In this interview Phil talks us through the..
Avation PLC (LON:AVAP) Executive Chairman Jeff Chatfield joins DirectorsTalk Interviews to discuss its positioning following results for the year ended 30th June 2023. In this interview Jeff explains how the..
City of London Investment Group (LON:CLIG) is the topic of conversation when Dr. Brian Moretta, Head of Tax-Enhanced Services & Financial Analyst at Hardman & Co joins DirectorsTalk Interviews. In..
In this interview with Ilika plc‘s (LON:IKA) CEO, Graham Purdy, the focus is on the company’s recent £2.7 million grant from the Automotive Transformation Fund to scale up Goliath solid-state..
Apax Global Alpha (LON:APAX) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk. In this interview Mark delves into the key theme of resilience..
Line Hydrogen founder and executive chairman Brendan James joins DirectorsTalk Interviews to provide a fascinating insight into the company’s unique approach to large-scale hydrogen production and distribution, which differs significantly..
Zinc Media Group (LON:ZIN) CEO Mark Browning joins DirectorsTalk Interviews to discuss its Interim results for the six months ended 30 June. In this interview Mark Browning, the CEO of..
Silver Bullet Data Services Group (LON:SBDS) CEO Ian James joins DirectorsTalk Interviews to discuss interim results for the six months to 30 June 2023. Ian talks us through the financial..
Avingtrans PLC (LON:AVG) CEO Steve McQuillan and CFO Steve King join DirectorsTalk Interviews to discuss its results for the year ended 31st May 2023. In this interview both the CEO..
XP Factory plc (LON:XPF) CEO Richard Harpham joins DirectorsTalk Interviews to discuss interim results for the six months ended 30 June 2023. Richard talks us through the result financial highlights,..
Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss interim results for the six months ended 30 June 2023. In this interview Matthew talks us through..
Boku, Inc (LON:BOKU) CEO Jon Prideaux joins DirectorsTalk Interviews to discuss interim results for the six months ended 30 June 2023. Jon talks us through the financial highlights of the..
Wildcat Petroleum plc (LON:WCAT) Chairman Mandhir Singh joins DirectorsTalk Interviews to discuss an update on its plans in the Republic of Sudan. Mandhir explains why it intends to sign a..
Strix Group plc (LON:KETL) CEO Bark Bartlett joins DirectorsTalk Interviews to discuss its interim results for the six months ended 30 June 2023. Mark talks us through the highlights for..
The International Stock Exchange is the topic of conversation when Jason Streets, Analyst at Hardman & Co joins DirectorsTalk Interviews. Jason explains what The International Stock Exchange does, what makes..
Warpaint London (LON:W7L) CEO Sam Bazini joins DirectorsTalk Interviews to discuss its interim results for the six months ended 30th June 2023. In this interview Sam reminds us of what..
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman Dr Allan Syms joins DirectorsTalk Interviews to the completion of its Evaluation Programme with Bio-Techne for Cizzle’s CIZ1B cancer biomarker. Allan reminds us of..


































